DCM
PFE icon

DGS Capital Management’s Pfizer PFE Stock Holding History

DGS Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
+8,128
New +$216K 0.04% 506
2023
Q2 		– Sell
-6,055
Closed -$247K – 254
2023
Q1 		$247K Sell
6,055
-650
-10% -$28.1K 0.14% 168
2022
Q4 		$344K Buy
6,705
+341
+5% +$16.3K 0.22% 113
2022
Q3 		$278K Sell
6,364
-626
-9% -$30.4K 0.19% 124
2022
Q2 		$366K Sell
6,990
-377
-5% -$19.2K 0.3% 80
2022
Q1 		$381K Buy
7,367
+2,021
+38% +$105K 0.23% 89
2021
Q4 		$316K Buy
+5,346
New +$265K 0.2% 93

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

DGS Capital Management's PFE Position: Q1 2026 in Review

DGS Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 8,128 shares worth $228K. The stake represents 0.04% of the portfolio and ranks #506 among its holdings. This is a return to the name: DGS Capital Management previously reported a position in PFE as recently as Q1 2023.

DGS Capital Management first reported a position in PFE in Q4 2021 and has held it in 7 quarters since. The position peaked at $381K in Q1 2022. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • DGS Capital Management held 8,128 shares of Pfizer worth $228K as of Q1 2026.
  • Pfizer was a new DGS Capital Management position in Q1 2026.
  • Pfizer made up 0.04% of DGS Capital Management's portfolio in Q1 2026, its #506 holding.
  • DGS Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 7 quarters since.
  • DGS Capital Management's Pfizer position peaked at $381K in Q1 2022.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.